The albumin/creatinine ratio (ACR) is a valuable indicator of kidney function and plays a pivotal role in detecting early signs of kidney damage. It is commonly used to monitor kidney function in diabetes, although its clinical utility expands beyond that.
This article explores the clinical significance of ACR testing, from understanding its calculation to interpreting results and exploring management strategies.
Understanding the Albumin/Creatinine Ratio (ACR) is fundamental to appreciating its significance as a biomarker in renal health assessment.
The ACR represents the ratio between the concentrations of albumin and creatinine in urine samples. It is increasingly recognized as a prognostic marker for various significant health outcomes, including hypertension, kidney failure, cardiovascular events, and mortality. [5., 12.]
The ACR is associated with cardiometabolic risk factors, vascular disease, and insulin resistance. Observational studies have consistently linked ACR levels with incident diabetes, alongside other markers of urinary albumin excretion. [4.]
Albumin is not typically excreted in the urine in healthy populations; above a certain level, its presence in the urine may signal early kidney damage. The albumin to creatinine ratio compares levels of albumin to creatinine, a biomarker that typically stays relatively constant, to assess the degree of albumin loss in the urine. The greater the degree of albumin loss in the urine, the greater the likelihood and degree of kidney damage that has occurred.
The ACR detects levels of albumin in the urine that are undetectable via urine dipstick. [5.]
The calculation of ACR involves measuring the concentrations of albumin and creatinine in a urine sample. The ratio is then determined by dividing the albumin concentration by the creatinine concentration.
The ACR can detect microalbuminuria, or smaller amounts of albumin in urine which signals early kidney damage, as well as macroalbuminuria, or more significant amounts of albumin in urine, which signals a greater degree of kidney damage.
Elevated ACR levels may indicate renal impairment, glomerular damage, or other underlying kidney disorders, prompting further evaluation and intervention.
The laboratory procedure for measuring ACR involves analyzing a urine sample collected from the patient. This can be done using a spot urine sample or a 24 hour urine collection, which is tested for both albumin and creatinine concentrations. Clinically, the spot or random urine test is preferred over the 24 hour urine collection. [3.]
An elevated ACR on one occasion requires repeat testing. The diagnosis of microalbuminuria or macroalbuminuria requires at least 2 of 3 abnormal tests within a 3- to 6-month period. [3.]
A spot or random urine collection typically has the following reference range: [9.]
A 24 hour urine collection typically has the following reference ranges:
High ACR levels indicate an increased excretion of albumin in the urine, known as albuminuria or proteinuria. It is further broken down into microalbuminuria and macroalbuminuria.
Levels between 30 to 300 mg/g indicate microalbuminuria, which signals early kidney damage and has been associated with hypertension-related kidney disease, glomerulonephritis, chronic kidney disease (CKD), coronary artery disease, cardiovascular and all‐cause death in the general population. [12.]
It is also commonly used to assess diabetic nephropathy, or kidney disease due to diabetic complications. [5.]
Macroalbuminuria refers to a condition characterized by the presence of high levels of albumin in the urine, typically exceeding 300 milligrams/gram of creatinine.
It is often indicative of significant kidney damage and is associated with conditions such as diabetic nephropathy, hypertension, and other forms of kidney disease. Macroalbuminuria is an important clinical marker used to assess kidney function and evaluate the risk of progression to kidney failure and cardiovascular disease.
Several factors can contribute to elevated ACR levels including health conditions, some medications, and lifestyle factors.
Kidney damage: conditions such as diabetic nephropathy, glomerulonephritis and glomerular diseases such as membranous nephropathy or IgA nephropathy and other forms of renal impairment can lead to increased albumin excretion, raising the albumin/creatinine ratio.
Hypertension: high blood pressure can damage the kidneys over time, resulting in elevated levels of albumin in the urine. [12.]
Cardiovascular disease: heart failure and other cardiovascular conditions can lead to kidney damage and increased albuminuria. Increased ACR is also associated with elevated cholesterol and reduced serum HDL. [1., 12.]
Diabetes: diabetes can cause diabetic nephropathy, a common cause of elevated albumin/creatinine ratio. [4.]
Urinary tract infections: infections affecting the urinary tract can cause inflammation and lead to temporary increases in albumin excretion. [2.]
Exercise: intense physical activity may transiently increase albumin excretion, affecting the albumin/creatinine ratio. However, regular strenuous exercise reduces ACR, especially in nondiabetic women. [13.]
Fever: fever, often associated with infections or inflammatory conditions, can lead to temporary increased albumin excretion. [7.]
High animal-fat diet: consuming excessive amounts of animal fat, and 2 or more servings of red meat a week have been associated with elevated albumin levels in the urine. [8.]
Smoking: tobacco use has been linked to kidney damage and may contribute to elevated albuminuria. [6.]
Obesity: obesity is positively correlated with an elevated albumin/creatinine ratio, suggesting that excess adiposity may contribute to renal dysfunction and increased urinary albumin excretion. [11.]
Addressing elevated Albumin/Creatinine Ratio (ACR) levels is essential in managing renal health and preventing further kidney damage. Lifestyle modifications play a crucial role in reducing ACR and promoting overall kidney health.
In addition to lifestyle modifications, medical interventions are often necessary to lower ACR levels effectively.
Lowering Albumin/Creatinine Ratio (ACR) levels requires a comprehensive approach involving lifestyle modifications and medical interventions.
By promoting healthy lifestyle habits, managing underlying health conditions, and implementing targeted medical therapies, healthcare providers can effectively reduce ACR levels, slow the progression of kidney disease, and improve renal outcomes for patients.
Click here to compare albumin/creatinine ratio tests and order testing.
[1.] Bakris GL. Microalbuminuria: what is it? Why is it important? What should be done about it? J Clin Hypertens (Greenwich). 2001 Mar-Apr;3(2):99-102. doi: 10.1111/j.1524-6175.2001.00442.x. PMID: 11416691; PMCID: PMC8101897.
[2.] Chou YJ, Yang CC, Chang SJ, Yang SS. Albuminuria Is Affected by Urinary Tract Infection: A Comparison between Biochemical Quantitative Method and Automatic Urine Chemistry Analyzer UC-3500. Diagnostics (Basel). 2023 Nov 2;13(21):3366. doi: 10.3390/diagnostics13213366. PMID: 37958262; PMCID: PMC10650489.
[3.] DynaMedex. www.dynamedex.com. Accessed March 26, 2024. https://www.dynamedex.com/lab-monograph/microalbuminuria-measurement-24-hour-collection-urine#GUID-2D9B303B-793A-4776-9245-81A57E6688AA
[4.] Friedman AN, Marrero D, Ma Y, Ackermann R, Narayan KM, Barrett-Connor E, Watson K, Knowler WC, Horton ES; Diabetes Prevention Program Research Group. Value of urinary albumin-to-creatinine ratio as a predictor of type 2 diabetes in pre-diabetic individuals. Diabetes Care. 2008 Dec;31(12):2344-8. doi: 10.2337/dc08-0148. Epub 2008 Sep 16. Erratum in: Diabetes Care. 2009 May;32(5):968.. Friedman, Allon [corrected to Friedman, Allon N]. PMID: 18796622; PMCID: PMC2584193.
[5.] Garg D, Naugler C, Bhella V, Yeasmin F. Chronic kidney disease in type 2 diabetes: Does an abnormal urine albumin-to-creatinine ratio need to be retested? Can Fam Physician. 2018 Oct;64(10):e446-e452. PMID: 30315036; PMCID: PMC6184958.
[6.] Gupta R, Gupta R, Maheshwari V, Mawliya M. Impact of smoking on microalbuminuria and urinary albumin creatinine ratio in non-diabetic normotensive smokers. Indian Journal of Nephrology. 2014;24(2):92. doi:https://doi.org/10.4103/0971-4065.127893
[7.] Gurevich E, Israel E, Segev Y, Landau D. Febrile Proteinuria in Hospitalized Children: Characterization of Urinary Proteins. Front Pediatr. 2018 Aug 17;6:202. doi: 10.3389/fped.2018.00202. PMID: 30175088; PMCID: PMC6107750.
[8.] Lin J, Hu FB, Curhan GC. Associations of diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol. 2010 May;5(5):836-43. doi: 10.2215/CJN.08001109. Epub 2010 Mar 18. PMID: 20299364; PMCID: PMC2863979.
[9.] Microalbumin: Reference Range, Interpretation, Collection and Panels. eMedicine. Published online July 19, 2021. https://emedicine.medscape.com/article/2088184-overview#a1
[10.] Qiao Y, Shin JI, Chen TK, Sang Y, Coresh J, Vassalotti JA, Chang AR, Grams ME. Association of Albuminuria Levels With the Prescription of Renin-Angiotensin System Blockade. Hypertension. 2020 Dec;76(6):1762-1768. doi: 10.1161/HYPERTENSIONAHA.120.15956. Epub 2020 Sep 28. PMID: 32981368; PMCID: PMC7666106.
[11.] Qin S, Wang A, Gu S, Wang W, Gao Z, Tang X, Yan L, Wan Q, Luo Z, Qin G, Chen L, Ning G, Mu Y. Association between obesity and urinary albumin-creatinine ratio in the middle-aged and elderly population of Southern and Northern China: a cross-sectional study. BMJ Open. 2021 Jan 5;11(1):e040214. doi: 10.1136/bmjopen-2020-040214. PMID: 33402405; PMCID: PMC7786798.
[12.] Ren F, Li M, Xu H, Qin X, Teng Y. Urine albumin-to-creatinine ratio within the normal range and risk of hypertension in the general population: A meta-analysis. J Clin Hypertens (Greenwich). 2021 Jul;23(7):1284-1290. doi: 10.1111/jch.14263. Epub 2021 Jun 5. PMID: 34089300; PMCID: PMC8678728.
[13.] Robinson ES, Fisher ND, Forman JP, Curhan GC. Physical activity and albuminuria. Am J Epidemiol. 2010 Mar 1;171(5):515-21. doi: 10.1093/aje/kwp442. Epub 2010 Feb 4. PMID: 20133515; PMCID: PMC2842220.
[14.] Shihabi ZK, Konen JC, O'Connor ML: Albuminuria vs urinary total protein for detecting chronic renal disorders. Clin Chem 1991; 37(5):621-624.